(3R,10S,13S,16S,19S)-16-[(2S)-butan-2-yl]-3,10,11,14-tetramethyl-13-propan-2-yl-4-oxa-1,8,11,14,17-pentazabicyclo[17.3.0]docosane-2,5,9,12,15,18-hexone

C27H45N5O7 — CID 10482713

IUPAC(3R,10S,13S,16S,19S)-16-[(2S)-butan-2-yl]-3,10,11,14-tetramethyl-13-propan-2-yl-4-oxa-1,8,11,14,17-pentazabicyclo[17.3.0]docosane-2,5,9,12,15,18-hexone
SMILESCC[C@H](C)[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@@H](C)OC(=O)CCNC(=O)[C@H](C)N(C)C(=O)[C@H](C(C)C)N(C)C1=O
InChIInChI=1S/C27H45N5O7/c1-9-16(4)21-26(37)31(8)22(15(2)3)27(38)30(7)17(5)23(34)28-13-12-20(33)39-18(6)25(36)32-14-10-11-19(32)24(35)29-21/h15-19,21-22H,9-14H2,1-8H3,(H,28,34)(H,29,35)/t16-,17-,18+,19-,21-,22-/m0/s1
InChIKeyURHGAJXNFCHPRB-XVLZDAOXSA-N
MW551.69 g/mol
LogP0.29
Rot. Bonds3

About (3R,10S,13S,16S,19S)-16-[(2S)-butan-2-yl]-3,10,11,14-tetramethyl-13-propan-2-yl-4-oxa-1,8,11,14,17-pentazabicyclo[17.3.0]docosane-2,5,9,12,15,18-hexone

(3R,10S,13S,16S,19S)-16-[(2S)-butan-2-yl]-3,10,11,14-tetramethyl-13-propan-2-yl-4-oxa-1,8,11,14,17-pentazabicyclo[17.3.0]docosane-2,5,9,12,15,18-hexone (PubChem CID 10482713) has the molecular formula C27H45N5O7 and a molecular weight of 551.69 g/mol. Its IUPAC name is (3R,10S,13S,16S,19S)-16-[(2S)-butan-2-yl]-3,10,11,14-tetramethyl-13-propan-2-yl-4-oxa-1,8,11,14,17-pentazabicyclo[17.3.0]docosane-2,5,9,12,15,18-hexone.

Molecular Properties

Compound Name(3R,10S,13S,16S,19S)-16-[(2S)-butan-2-yl]-3,10,11,14-tetramethyl-13-propan-2-yl-4-oxa-1,8,11,14,17-pentazabicyclo[17.3.0]docosane-2,5,9,12,15,18-hexone
PubChem CID10482713
Molecular FormulaC27H45N5O7
Molecular Weight551.69 g/mol
Exact Mass551.33
IUPAC Name(3R,10S,13S,16S,19S)-16-[(2S)-butan-2-yl]-3,10,11,14-tetramethyl-13-propan-2-yl-4-oxa-1,8,11,14,17-pentazabicyclo[17.3.0]docosane-2,5,9,12,15,18-hexone
SMILESCC[C@H](C)[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@@H](C)OC(=O)CCNC(=O)[C@H](C)N(C)C(=O)[C@H](C(C)C)N(C)C1=O
InChIInChI=1S/C27H45N5O7/c1-9-16(4)21-26(37)31(8)22(15(2)3)27(38)30(7)17(5)23(34)28-13-12-20(33)39-18(6)25(36)32-14-10-11-19(32)24(35)29-21/h15-19,21-22H,9-14H2,1-8H3,(H,28,34)(H,29,35)/t16-,17-,18+,19-,21-,22-/m0/s1
InChIKeyURHGAJXNFCHPRB-XVLZDAOXSA-N
XLogP0.29
TPSA145.43 Ų
H-Bond Donors2
H-Bond Acceptors7
Rotatable Bonds3
Heavy Atoms39
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500551.69
LogP ≤ 50.29
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 107

Analyze (3R,10S,13S,16S,19S)-16-[(2S)-butan-2-yl]-3,10,11,14-tetramethyl-13-propan-2-yl-4-oxa-1,8,11,14,17-pentazabicyclo[17.3.0]docosane-2,5,9,12,15,18-hexone with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (3R,10S,13S,16S,19S)-16-[(2S)-butan-2-yl]-3,10,11,14-tetramethyl-13-propan-2-yl-4-oxa-1,8,11,14,17-pentazabicyclo[17.3.0]docosane-2,5,9,12,15,18-hexone?
The IUPAC name of (3R,10S,13S,16S,19S)-16-[(2S)-butan-2-yl]-3,10,11,14-tetramethyl-13-propan-2-yl-4-oxa-1,8,11,14,17-pentazabicyclo[17.3.0]docosane-2,5,9,12,15,18-hexone (CID 10482713) is (3R,10S,13S,16S,19S)-16-[(2S)-butan-2-yl]-3,10,11,14-tetramethyl-13-propan-2-yl-4-oxa-1,8,11,14,17-pentazabicyclo[17.3.0]docosane-2,5,9,12,15,18-hexone.
What is the SMILES notation for (3R,10S,13S,16S,19S)-16-[(2S)-butan-2-yl]-3,10,11,14-tetramethyl-13-propan-2-yl-4-oxa-1,8,11,14,17-pentazabicyclo[17.3.0]docosane-2,5,9,12,15,18-hexone?
The canonical SMILES for (3R,10S,13S,16S,19S)-16-[(2S)-butan-2-yl]-3,10,11,14-tetramethyl-13-propan-2-yl-4-oxa-1,8,11,14,17-pentazabicyclo[17.3.0]docosane-2,5,9,12,15,18-hexone is CC[C@H](C)[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@@H](C)OC(=O)CCNC(=O)[C@H](C)N(C)C(=O)[C@H](C(C)C)N(C)C1=O.
What is the InChIKey of (3R,10S,13S,16S,19S)-16-[(2S)-butan-2-yl]-3,10,11,14-tetramethyl-13-propan-2-yl-4-oxa-1,8,11,14,17-pentazabicyclo[17.3.0]docosane-2,5,9,12,15,18-hexone?
The InChIKey is URHGAJXNFCHPRB-XVLZDAOXSA-N. The full InChI is InChI=1S/C27H45N5O7/c1-9-16(4)21-26(37)31(8)22(15(2)3)27(38)30(7)17(5)23(34)28-13-12-20(33)39-18(6)25(36)32-14-10-11-19(32)24(35)29-21/h15-19,21-22H,9-14H2,1-8H3,(H,28,34)(H,29,35)/t16-,17-,18+,19-,21-,22-/m0/s1.
What are the key properties of (3R,10S,13S,16S,19S)-16-[(2S)-butan-2-yl]-3,10,11,14-tetramethyl-13-propan-2-yl-4-oxa-1,8,11,14,17-pentazabicyclo[17.3.0]docosane-2,5,9,12,15,18-hexone?
(3R,10S,13S,16S,19S)-16-[(2S)-butan-2-yl]-3,10,11,14-tetramethyl-13-propan-2-yl-4-oxa-1,8,11,14,17-pentazabicyclo[17.3.0]docosane-2,5,9,12,15,18-hexone has a molecular weight of 551.69 g/mol, XLogP of 0.29, 3 rotatable bonds, 2 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for (3R,10S,13S,16S,19S)-16-[(2S)-butan-2-yl]-3,10,11,14-tetramethyl-13-propan-2-yl-4-oxa-1,8,11,14,17-pentazabicyclo[17.3.0]docosane-2,5,9,12,15,18-hexone is sourced from PubChem (CID 10482713), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).